- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05208489
Direct Peritoneal Resuscitation for Intra-abdominal Catastrophes
January 13, 2022 updated by: Kartik Prabhakaran, New York Medical College
It is a retrospective study.
Patients, who presented with either traumatic or general surgery emergencies, undergone exploratory laparotomy, had an open abdomen management and received Direct Peritoneal Resuscitation in addition to standard resuscitation will be considered as meeting the criteria to collect the data.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Due to the high volume of patient transfers from different facilities with difficult intra-abdominal pathologies and the high case-mix index at Westchester Medical Center, we see many patients who require re-operations and open abdominal management.
Since July1st of 2020 we have been using DPR in addition to standard iv fluids on all patients who undergo open abdominal management and it is now standard of care at our facility.
we plan to collect the data from all qualified subjects who received DRP since 7/1/2020 to 6/30/2022.
Study Type
Observational
Enrollment (Anticipated)
108
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Anuritha Tirumani, MBBS
- Phone Number: 914-493-3470
- Email: anuritha.tirumani@wmchealth.org
Study Contact Backup
- Name: Abbas Smiley, MD
- Phone Number: 914-493-3470
- Email: abbas.smiley@wmchealth.org
Study Locations
-
-
New York
-
Valhalla, New York, United States, 10595
- Recruiting
- New York Medical College
-
Contact:
- Abbas Smiley, MD
- Phone Number: 914-493-3470
- Email: abbas.smiley@wmchealth.org
-
Contact:
- Anuritha Tirumani
- Phone Number: 914-493-3470
- Email: anuritha.tirumani@wmchealth.org
-
Principal Investigator:
- Kartik Prabhakaran, MD
-
Sub-Investigator:
- Rifat Latifi, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adult patients 18 and above, who presents with either traumatic or general surgery emergencies and undergone exploratory laparotomy had an open abdomen management and received DPR in addition to standard resuscitation will be considered as meeting the criteria to be in the study.
Description
Inclusion Criteria:
- Adult patients 18 years of age or older.
- Trauma or General surgery patients who undergo emergency abdominal surgery via laparotomy and who had open abdominal management during the index procedure at our institution.
- Patients who are transferred to our institution with an already open abdomen will also be eligible if they required continued open abdominal management.
Exclusion Criteria:
- Patients <18 years are excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post operative outcomes
Time Frame: through out the hospitalization and 30 days after discharge.
|
intra abdominal infections and other complications
|
through out the hospitalization and 30 days after discharge.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
length of hospital stay
Time Frame: post procedure to 30 days after discharge.
|
includes ICU stay, ventilator days and mortality.
|
post procedure to 30 days after discharge.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kartik Prabhakaran, MD, New York Medical College
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Smith JW, Garrison RN, Matheson PJ, Franklin GA, Harbrecht BG, Richardson JD. Direct peritoneal resuscitation accelerates primary abdominal wall closure after damage control surgery. J Am Coll Surg. 2010 May;210(5):658-64, 664-7. doi: 10.1016/j.jamcollsurg.2010.01.014.
- Zakaria el R, Hurt RT, Matheson PJ, Garrison RN. A novel method of peritoneal resuscitation improves organ perfusion after hemorrhagic shock. Am J Surg. 2003 Nov;186(5):443-8. doi: 10.1016/j.amjsurg.2003.07.006.
- Crafts TD, Hunsberger EB, Jensen AR, Rescorla FJ, Yoder MC, Markel TA. Direct peritoneal resuscitation improves survival and decreases inflammation after intestinal ischemia and reperfusion injury. J Surg Res. 2015 Dec;199(2):428-34. doi: 10.1016/j.jss.2015.06.031. Epub 2015 Jun 18.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 16, 2021
Primary Completion (ANTICIPATED)
June 30, 2022
Study Completion (ANTICIPATED)
June 1, 2023
Study Registration Dates
First Submitted
December 28, 2021
First Submitted That Met QC Criteria
January 13, 2022
First Posted (ACTUAL)
January 26, 2022
Study Record Updates
Last Update Posted (ACTUAL)
January 26, 2022
Last Update Submitted That Met QC Criteria
January 13, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14677
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
no plan as of now
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intestinal Obstruction
-
Jinling Hospital, ChinaCompletedChronic Intestinal Pseudo ObstructionChina
-
MovetisCompletedChronic Intestinal Pseudo-ObstructionUnited Kingdom
-
Centre Hospitalier Universitaire de NiceActive, not recruitingSmall Bowel Obstruction | Intestinal Pseudo-ObstructionFrance
-
Marina ColettaNottingham University Hospitals NHS Trust; Fondazione I.R.C.C.S. Istituto Neurologico...Enrolling by invitation
-
Alfasigma S.p.A.CompletedChronic Intestinal Pseudo-obstructionBelgium, Italy, Spain
-
International University of Health and WelfareNot yet recruitingChronic Intestinal Pseudo-obstructionJapan
-
University of NottinghamNorthern Care Alliance NHS Foundation Trust; Cambridge University Hospitals... and other collaboratorsRecruiting
-
University Hospital, LinkoepingLinkoeping University; Region Jönköping CountyNot yet recruitingSmall Bowel Obstruction | Intestinal Obstruction and IleusSweden
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldRecruitingIleus | Small Bowel Obstruction | Intestinal FailureUnited Kingdom
-
University Hospital, GrenobleRecruiting
Clinical Trials on there is no intervention involved in this study
-
University of Texas Southwestern Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruiting
-
The University of Hong KongTerminatedObstructive Sleep Apnea | Endothelial Dysfunction | Cardiac Syndrome XHong Kong
-
Istanbul University - CerrahpasaCompletedCardiovascular Diseases | Surgery | Anesthesia | Cardiac Disease | Perioperative/Postoperative Complications | Cardiovascular ComplicationTurkey (Türkiye)
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOcular Hypertension | Glaucoma, Open-AngleCanada
-
University of GeorgiaCompletedHuman PapillomavirusUnited States
-
Chinese PLA General HospitalNot yet recruitingCoronary Artery DiseaseChina
-
Istanbul University - CerrahpasaCompletedCardiovascular Diseases | Anesthesia | Cardiovascular ComplicationTurkey (Türkiye)
-
ProgenaBiomeSuspendedDepression | Multiple Sclerosis | Diabetes | Cancer | Parkinson Disease | Constipation | Migraine | Amyotrophic Lateral Sclerosis | Psoriasis | Anxiety | Alzheimer Disease | Bipolar and Related Disorders | Celiac Disease | Eczema | Autism Spectrum Disorder | Mesothelioma | Colon Cancer | Amyotrophic Lateral Sclerosis (ALS) | Gout | Lyme Arthritis and other conditionsUnited States
-
Unity Health TorontoSunnybrook Health Sciences Centre; University of British Columbia; Alberta Health... and other collaboratorsCompleted
-
ProgenaBiomeRecruitingCoronaviridae Infections | COVID-19 | COVID 19 | COVID | Corona Virus Infection | Coronavirus | Gastrointestinal Microbiome | Gut Microbiome | Coronavirus-19 | Coronavirus 19United States